收费全文 | 103470篇 |
免费 | 9975篇 |
国内免费 | 3202篇 |
耳鼻咽喉 | 831篇 |
儿科学 | 1179篇 |
妇产科学 | 980篇 |
基础医学 | 12058篇 |
口腔科学 | 3672篇 |
临床医学 | 10940篇 |
内科学 | 10788篇 |
皮肤病学 | 1291篇 |
神经病学 | 6645篇 |
特种医学 | 3173篇 |
外国民族医学 | 11篇 |
外科学 | 7098篇 |
综合类 | 15109篇 |
现状与发展 | 8篇 |
一般理论 | 3篇 |
预防医学 | 17248篇 |
眼科学 | 1210篇 |
药学 | 13873篇 |
120篇 | |
中国医学 | 5828篇 |
肿瘤学 | 4582篇 |
2024年 | 450篇 |
2023年 | 1961篇 |
2022年 | 4098篇 |
2021年 | 5106篇 |
2020年 | 4873篇 |
2019年 | 4210篇 |
2018年 | 3810篇 |
2017年 | 4095篇 |
2016年 | 4138篇 |
2015年 | 4056篇 |
2014年 | 7118篇 |
2013年 | 7617篇 |
2012年 | 6825篇 |
2011年 | 7160篇 |
2010年 | 5364篇 |
2009年 | 4992篇 |
2008年 | 4766篇 |
2007年 | 4740篇 |
2006年 | 4038篇 |
2005年 | 3544篇 |
2004年 | 2936篇 |
2003年 | 2684篇 |
2002年 | 2105篇 |
2001年 | 1985篇 |
2000年 | 1563篇 |
1999年 | 1360篇 |
1998年 | 1298篇 |
1997年 | 1177篇 |
1996年 | 1013篇 |
1995年 | 921篇 |
1994年 | 889篇 |
1993年 | 688篇 |
1992年 | 656篇 |
1991年 | 549篇 |
1990年 | 478篇 |
1989年 | 491篇 |
1988年 | 425篇 |
1987年 | 372篇 |
1986年 | 288篇 |
1985年 | 380篇 |
1984年 | 295篇 |
1983年 | 177篇 |
1982年 | 200篇 |
1981年 | 155篇 |
1980年 | 155篇 |
1979年 | 116篇 |
1978年 | 76篇 |
1977年 | 54篇 |
1976年 | 72篇 |
1974年 | 41篇 |
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献Findings: A 30-year-old man with complete paraplegia used the HAL® for 1 month (10 sessions) using his remaining muscle activity, including hip flexor and upper limb activity. Electromyography was used to evaluate muscle activity of the gluteus maximus, tensor fascia lata, quadriceps femoris, and hamstring muscles in synchronization with the Vicon motion capture system. A HAL® session included a knee extension session with the hip flexor and voluntary gait with upper limb activity. After using the HAL® for one month, the patient’s manual muscle hip flexor scores improved from 1/5 to 2/5 for the right and from 2/5 to 3/5 for the left knee, and from 0/5 to 1/5 for the extension of both knees.
Conclusion/clinical relevance: Knee extension sessions with HAL®, and hip flexor and upper-limb-triggered HAL® ambulation seem a safe and feasible option in a patient with complete paraplegia due to spinal cord injury. 相似文献